Triglycerides of fatty acids
AssigneeScotia Holdings PLC
InventorsDavid F. Horrobin, Philip Knowles, Mehar Singh Manku, Austin McMordie
Life of this patent
Estimating the term…
Abstract
A triglyceride for use in therapy or as a nutritional supplement, or a composition containing a triglyceride, wherein the triglyceride comprises a fatty acid selected from gamma-linolenic acid and the n-6 EPAs naturally derived therefrom and stearidonic acid and the n-3 EFAs naturally derived therefrom, forming a triple ester with glycerol or alternatively forming a double ester in which the other esterifying acide is a single residue of linoleic acid, with the proviso that the di-gammalinolenoyl-mono-linoleoyl glyceride if selected is used as a preparation containing more than 20% by weight thereof.
Claims14
A pharmaceutical or dietary composition comprising a triglyceride containing three residues of the same fatty acid selected from the group consisting of a 22:4 n-6 acid, a 22:5 n-6 acid, stearidonic acid, a 20:4 n-3 acid, and a 22:5 n-3 acid in the form of a triple ester with glycerol, wherein said triglyceride forms more than 10% by weight of the triglycerides present.
A pharmaceutical or dietary composition comprising a triglyceride containing two residues of the same essential fatty acid (EFA) selected from the group consisting of dihomo-gamma-linolenic acid and the n-6 EFAs naturally derived therefrom and stearidonic acid and the n-3 EFAs naturally derived therefrom, in the form of a 1,2-double ester with glycerol in which the other esterifying acid is a single residue of linoleic acid, wherein said triglyceride forms more than 10% by weight of the triglycerides present.
A pharmaceutical or dietary composition comprising a triglyceride containing two residues of the same fatty acid selected from the group consisting of dihomo-gamma-linolenic acid and the n-6 EFAs naturally derived therefrom, stearidonic acid, a 20:4 n-3 acid and a 22:5 n-3 acid, in the form of a 1,3-double ester with glycerol in which the other esterifying acid is a single residue of linoleic acid, wherein said triglyceride forms more than 10% by weight of the triglycerides present.
A pharmaceutical or dietary composition comprising a triglyceride containing three residues of the 22:6 n-3 acid in the form of a triple ester with glycerol, wherein said triglyceride is more than 40% by weight of the triglycerides present.
A triglyceride comprising a fatty add selected from the group consisting of a 22:4 n-6 acid, a 22:5 n-6 acid, a 20:4 n-3 acid, a 22:5 n-3 acid in the form of a triple ester with glycerol.
A triglyceride comprising two residues of the same fatty add selected from the group consisting of dihomo-gamma-linolenic acid and the n-6 EFAs naturally derived therefrom and a 20:4 n-3 acid and a n-3 EFAs naturally derived therefrom in the form of a 1,2-double ester with glycerol in which the other esterifying acid is a single residue of linoleic acid.
A triglyceride comprising two residues of the same fatty acid selected from the group consisting of dihomo-gamma-linolenic acid and the n-6 EFAs naturally derived therefrom, a 20:4 n-3 acid and a 22:5 n-3 acid, in the form of a 1,3-double ester with glycerol in which the other esterifying acid is a single residue of linoleic acid.
Dependencies are inferred from the claim text.